BioPharmX down 15% after hours on 1:25 reverse stock split

|About: BioPharmX Corporation (BPMX)|By:, SA News Editor

Aimed at regaining compliance with NYSE American listing requirements, BioPharmX (NYSEMKT:BPMX) will execute a 1:25 reverse split of its common stock on April 25. Post-split trading will commence on April 26.

Shares are down 15% after hours.

Subscribe for full text news in your inbox